Biopsy-based management improved the @-year rate of distant disease-free survival ( hazard ratio for distant metastasis , @ ; P = @ ) and the @-year rate of melanoma-specific survival ( hazard ratio for death from melanoma , @ ; P = @ ) for patients with intermediate-thickness melanomas and nodal metastases .